Interview with Pedro Baptista – ConSalud.es
Pedro Baptista, ARAID researcher at the IIS Aragón and leader of WP7 – Bioconstruct in vivo validation in NEOLIVER project, was recently interviewed by ConSalud.es, an Spanish health journal.
In this interview, Pedro explains what is regenerative medicine, how will it revolutionize the the current shortage of organs and how NEOLIVER project contributes in this field.
NEOLIVER is an EU-funded project to develop large, dense, and vascularized bioprinted liver constructs from patient derived-organoids. NEOLIVER aims to produce the first autologous liver fully functional and suitable for transplantation.
